BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Esteva-Font C, Anderson MO, Verkman AS. Urea transporter proteins as targets for small-molecule diuretics. Nat Rev Nephrol 2015;11:113-23. [PMID: 25488859 DOI: 10.1038/nrneph.2014.219] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Hailemariam S, Zhao S, He Y, Wang J. Urea transport and hydrolysis in the rumen: A review. Anim Nutr 2021;7:989-96. [PMID: 34738029 DOI: 10.1016/j.aninu.2021.07.002] [Reference Citation Analysis]
2 Padhi S, Priyakumar UD. Urea–Aromatic Stacking and Concerted Urea Transport: Conserved Mechanisms in Urea Transporters Revealed by Molecular Dynamics. J Chem Theory Comput 2016;12:5190-200. [DOI: 10.1021/acs.jctc.6b00602] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
3 Cheng CJ, Rodan AR, Huang CL. Emerging Targets of Diuretic Therapy. Clin Pharmacol Ther 2017;102:420-35. [PMID: 28560800 DOI: 10.1002/cpt.754] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
4 Tominaga N, Kida K, Inomata T, Sato N, Izumi T, Akashi YJ, Shibagaki Y. Comparison of the effects of tolvaptan and furosemide on renal water and sodium excretion in patients with heart failure and advanced chronic kidney disease: a subanalysis of the K-STAR study. Clin Exp Nephrol 2018;22:1395-403. [PMID: 29934667 DOI: 10.1007/s10157-018-1603-1] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Teoh CW, Robinson LA, Noone D. Perspectives on edema in childhood nephrotic syndrome. Am J Physiol Renal Physiol 2015;309:F575-82. [PMID: 26290369 DOI: 10.1152/ajprenal.00229.2015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
6 Ran JH, Li M, Tou WI, Lei TL, Zhou H, Chen CY, Yang BX. Phenylphthalazines as small-molecule inhibitors of urea transporter UT-B and their binding model. Acta Pharmacol Sin 2016;37:973-83. [PMID: 27238209 DOI: 10.1038/aps.2016.4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
7 Li M, Zhao Y, Zhang S, Xu Y, Wang SY, Li BW, Ran JH, Li RT, Yang BX. A thienopyridine, CB-20, exerts diuretic activity by inhibiting urea transporters. Acta Pharmacol Sin 2020;41:65-72. [PMID: 31213671 DOI: 10.1038/s41401-019-0245-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
8 Zhang S, Zhao Y, Wang S, Li M, Xu Y, Ran J, Geng X, He J, Meng J, Shao G, Zhou H, Ge Z, Chen G, Li R, Yang B. Discovery of novel diarylamides as orally active diuretics targeting urea transporters. Acta Pharm Sin B 2021;11:181-202. [PMID: 33532188 DOI: 10.1016/j.apsb.2020.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
9 Raghunathan S, Jaganade T, Priyakumar UD. Urea-aromatic interactions in biology. Biophys Rev 2020;12:65-84. [PMID: 32067192 DOI: 10.1007/s12551-020-00620-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
10 Titko T, Perekhoda L, Drapak I, Tsapko Y. Modern trends in diuretics development. Eur J Med Chem 2020;208:112855. [PMID: 33007663 DOI: 10.1016/j.ejmech.2020.112855] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Han M, Chen LY. Molecular dynamics simulation of human urea transporter B. Molecular Simulation 2021;47:1022-8. [DOI: 10.1080/08927022.2021.1941944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Nandi S, Sanyal S, Amin SA, Kashaw SK, Jha T, Gayen S. Urea transporter and its specific and nonspecific inhibitors: State of the art and pharmacological perspective. Eur J Pharmacol 2021;911:174508. [PMID: 34536365 DOI: 10.1016/j.ejphar.2021.174508] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wagner CA. Pendrin-A New Target for Diuretic Therapy? J Am Soc Nephrol 2016;27:3499-501. [PMID: 27516234 DOI: 10.1681/ASN.2016070720] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wang S, Xu Y, Zhao Y, Zhang S, Li M, Li X, He J, Zhou H, Ge Z, Li R, Yang B. N-(4-acetamidophenyl)-5-acetylfuran-2-carboxamide as a novel orally available diuretic that targets urea transporters with improved PD and PK properties. Eur J Med Chem 2021;226:113859. [PMID: 34601246 DOI: 10.1016/j.ejmech.2021.113859] [Reference Citation Analysis]
15 Latek D, Rutkowska E, Niewieczerzal S, Cielecka-Piontek J. Drug-induced diabetes type 2: In silico study involving class B GPCRs. PLoS One 2019;14:e0208892. [PMID: 30650080 DOI: 10.1371/journal.pone.0208892] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
16 Lee S, Cil O, Diez-Cecilia E, Anderson MO, Verkman AS. Nanomolar-Potency 1,2,4-Triazoloquinoxaline Inhibitors of the Kidney Urea Transporter UT-A1. J Med Chem 2018;61:3209-17. [PMID: 29589443 DOI: 10.1021/acs.jmedchem.8b00343] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
17 Ghosh AK, Brindisi M. Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry. J Med Chem 2020;63:2751-88. [PMID: 31789518 DOI: 10.1021/acs.jmedchem.9b01541] [Cited by in Crossref: 41] [Cited by in F6Publishing: 23] [Article Influence: 13.7] [Reference Citation Analysis]
18 Zhang ZY, Wang X, Liu D, Zhang H, Zhang Q, Lu YY, Li P, Lou YQ, Yang BX, Lu C, Lou YX, Zhang GL. Development and validation of an LC-MS/MS method for the determination of a novel thienoquinolin urea transporter inhibitor PU-48 in rat plasma and its application to a pharmacokinetic study. Biomed Chromatogr 2018;32. [PMID: 29193233 DOI: 10.1002/bmc.4157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
19 Mori T, Ohsaki Y, Oba-yabana I, Ito S. Diuretic usage for protection against end-organ damage in liver cirrhosis and heart failure: Diuretic usage in volume overload diseases. Hepatol Res 2017;47:11-22. [DOI: 10.1111/hepr.12700] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
20 Zhao Y, Li M, Li B, Zhang S, Su A, Xing Y, Ge Z, Li R, Yang B. Discovery and optimization of thienopyridine derivatives as novel urea transporter inhibitors. Eur J Med Chem 2019;172:131-42. [PMID: 30959323 DOI: 10.1016/j.ejmech.2019.03.060] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
21 Klein JD, Sands JM. Urea transport and clinical potential of urearetics. Curr Opin Nephrol Hypertens 2016;25:444-51. [PMID: 27367911 DOI: 10.1097/MNH.0000000000000252] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
22 Bishai WR, Timmins GS. Potential for breath test diagnosis of urease positive pathogens in lung infections. J Breath Res 2019;13:032002. [DOI: 10.1088/1752-7163/ab2225] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Zhang ZY, Zhang H, Liu D, Lu YY, Wang X, Li P, Lou YQ, Yang BX, Lou YX, Lu C, Zhang Q, Zhang GL. Pharmacokinetics, Tissue Distribution and Excretion of a Novel Diuretic (PU-48) in Rats. Pharmaceutics 2018;10:E124. [PMID: 30096833 DOI: 10.3390/pharmaceutics10030124] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
24 Lee S, Esteva-Font C, Phuan PW, Anderson MO, Verkman AS. Discovery, synthesis and structure-activity analysis of symmetrical 2,7-disubstituted fluorenones as urea transporter inhibitors. Medchemcomm 2015;6:1278-84. [PMID: 26191399 DOI: 10.1039/C5MD00198F] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
25 Yahouédéhou SCMA, Neres JSDS, da Guarda CC, Carvalho SP, Santiago RP, Figueiredo CVB, Fiuza LM, Ndidi US, de Oliveira RM, Fonseca CA, Nascimento VML, Rocha LC, Adanho CSA, da Rocha TSC, Adorno EV, Goncalves MS. Sickle Cell Anemia: Variants in the CYP2D6, CAT, and SLC14A1 Genes Are Associated With Improved Hydroxyurea Response. Front Pharmacol 2020;11:553064. [PMID: 33013391 DOI: 10.3389/fphar.2020.553064] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]